Bromodomain-containing 2, BRD2, is a nuclear mitogen-activated kinase belonging to the BET family with a theoretical molecular weight of 88 kDa, typically running at 110 kDa on a Western Blot due post-translational modifications. In addition to regulating metabolism and metastatic cancer, BRD2 interacts with SARS-CoV-2 (COVID-19) Envelope protein. We offer antibodies from our extensive catalog to detect BRD2 including polyclonal antibodies, monoclonal antibodies, and recombinant rabbit monoclonal antibodies. Validated research applications include ELISA, ICC, Immunofluorescence, IHC, IHC-Paraffin, IP, Flow Cytometry, and Western Blot. Our BRD2 antibodies can be used in a variety of model species including Human, Mouse, Rat, Canine, and Bovine. Choose the anti-BRD2 antibody best suited for your research needs by viewing the technical details, images, references, reviews and related products. Each BRD2 antibody is fully covered by our Guarantee+.
Alternate Names for BRD2 Antibodies
anti-BRD2 antibody, anti-bromodomain containing 2 antibody, anti-bromodomain-containing 2 antibody, anti-bromodomain-containing protein 2 antibody, anti-D6S113E antibody, anti-female sterile homeotic-related gene 1 antibody, anti-FSRG1FSH antibody, anti-KIAA9001FLJ31942 antibody, anti-NAT antibody, anti-O27.1.1 antibody, anti-Really interesting new gene 3 protein antibody, anti-RING3DKFZp686N0336 antibody, anti-RNF3 antibody
8 Results for "brd2" in Primary Antibodies